Bariatrics Weight Loss Surgery and None-Surgical's Blog Los Angeles, CA

Groin pain may be quite troublesome, particularly if it interferes with movement, lifting, exercising, and resuming sporting activities. Inguinal hernia and sports hernia are two distinct conditions that are commonly confused for one another; however, despite their similar symptoms of groin pain or lower abdominal pain, they are two distinct ailments that require completely different…

The fundamental difference between Biliary Colic and Cholecystitis lies in the duration of the blockage and the presence of inflammation: biliary colic is a temporary obstruction of the cystic duct that causes intermittent pain, while cholecystitis is a persistent, inflammatory infection caused by a permanent blockage that requires immediate medical intervention. While biliary colic acts…

The conversation around weight-loss medication has moved quickly. While tirzepatide is already showing such promising results, can retatrutide possibly show even greater results in the future? This is a pertinent question that needs to be answered. Tirzepatide has already been approved by the FDA for the management of chronic weight in adults who are either…

Semaglutide has changed how we approach metabolic health and given people a strong option for managing chronic weight issues. However, individuals’ bodies respond differently to treatment. Understanding all possible semaglutide side effects helps individuals balance weight loss with long-term health. Before examining how the body responds to semaglutide, it is helpful to understand where this…

Obesity is no longer viewed simply as a failure of willpower. Modern medicine recognizes it as a complex metabolic disease, driven by hormonal signalling, insulin resistance, genetics, and environmental factors. Over the last few years, GLP-1-based medications have transformed how we approach non-surgical weight loss. Now, a next-generation investigational therapy, retatrutide, is pushing this field…

The market for weight-loss medications has been dominated by injectable GLP-1 receptor agonists, including Wegovy and Ozempic, for the past few years. These groundbreaking medications have helped prevent weight gain for millions of people. However, the need for weekly self-administered injections has remained a significant obstacle for numerous patients seeking bariatric and metabolic health assistance….

Does Ozempic Cause Hair Loss? What You Need to Know Ozempic is one of the most sought-after drugs in the United States, particularly for individuals seeking effective weight loss. Given that Ozempic belongs to the GLP-1 drug class, many people may be aware of its ability to suppress hunger, control blood sugar levels, and induce…

Both tirzepatide and semaglutide are breakthrough drugs in managing type 2 diabetes and obesity. In recent trials, tirzepatide was shown to achieve approximately 20% weight reduction, compared with 14% with semaglutide. The difference between these drugs largely lies in their mechanisms of action. While tirzepatide functions as a dual GIP/GLP-1 receptor agonist, semaglutide uses GLP-1…